These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34284036)

  • 1. Serial Circulating Tumor DNA Detection Using a Personalized, Tumor-Informed Assay in Esophageal Adenocarcinoma Patients Following Resection.
    Ococks E; Sharma S; Ng AWT; Aleshin A; Fitzgerald RC; Smyth E
    Gastroenterology; 2021 Nov; 161(5):1705-1708.e2. PubMed ID: 34284036
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma.
    Nelson DB; Dhupar R; Katkhuda R; Correa A; Goltsov A; Maru D; Sepesi B; Antonoff MB; Mehran RJ; Rice DC; Vaporciyan AA; Davila M; Davila R; Betancourt S; Ajani J; Hofstetter WL
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):406-413.e3. PubMed ID: 29605441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.
    Azad TD; Chaudhuri AA; Fang P; Qiao Y; Esfahani MS; Chabon JJ; Hamilton EG; Yang YD; Lovejoy A; Newman AM; Kurtz DM; Jin M; Schroers-Martin J; Stehr H; Liu CL; Hui AB; Patel V; Maru D; Lin SH; Alizadeh AA; Diehn M
    Gastroenterology; 2020 Feb; 158(3):494-505.e6. PubMed ID: 31711920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.
    Salati M; Venetis K; Fassan M; Malapelle U; Pagni F; Sajjadi E; Fusco N; Ghidini M
    Future Oncol; 2021 Nov; 17(33):4607-4618. PubMed ID: 34406032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring circulating tumor DNA by analyzing personalized cancer-specific rearrangements to detect recurrence in gastric cancer.
    Kim YW; Kim YH; Song Y; Kim HS; Sim HW; Poojan S; Eom BW; Kook MC; Joo J; Hong KM
    Exp Mol Med; 2019 Aug; 51(8):1-10. PubMed ID: 31395853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer.
    Tarazona N; Gimeno-Valiente F; Gambardella V; Zuñiga S; Rentero-Garrido P; Huerta M; Roselló S; Martinez-Ciarpaglini C; Carbonell-Asins JA; Carrasco F; Ferrer-Martínez A; Bruixola G; Fleitas T; Martín J; Tébar-Martínez R; Moro D; Castillo J; Espí A; Roda D; Cervantes A
    Ann Oncol; 2019 Nov; 30(11):1804-1812. PubMed ID: 31562764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma.
    Maron SB; Chase LM; Lomnicki S; Kochanny S; Moore KL; Joshi SS; Landron S; Johnson J; Kiedrowski LA; Nagy RJ; Lanman RB; Kim ST; Lee J; Catenacci DVT
    Clin Cancer Res; 2019 Dec; 25(23):7098-7112. PubMed ID: 31427281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiles in esophageal adenocarcinoma predict survival after resection.
    Pennathur A; Xi L; Litle VR; Gooding WE; Krasinskas A; Landreneau RJ; Godfrey TE; Luketich JD
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):505-12; discussion 512-3. PubMed ID: 23321130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma.
    Hsieh CC; Hsu HS; Chang SC; Chen YJ
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal Adenocarcinoma.
    Egyud M; Tejani M; Pennathur A; Luketich J; Sridhar P; Yamada E; Ståhlberg A; Filges S; Krzyzanowski P; Jackson J; Kalatskaya I; Jiao W; Nielsen G; Zhou Z; Litle V; Stein L; Godfrey T
    Ann Thorac Surg; 2019 Aug; 108(2):343-349. PubMed ID: 31059681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic correlations of superficial esophageal adenocarcinoma in endoscopic submucosal dissection specimens.
    Dhingra S; Bahdi F; May SB; Othman MO
    Diagn Pathol; 2021 Nov; 16(1):111. PubMed ID: 34838082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year experience of esophageal endoscopic submucosal dissection of superficial esophageal neoplasms in a single center.
    Park HC; Kim DH; Gong EJ; Na HK; Ahn JY; Lee JH; Jung KW; Choi KD; Song HJ; Lee GH; Jung HY; Kim JH
    Korean J Intern Med; 2016 Nov; 31(6):1064-1072. PubMed ID: 27618866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophagectomy versus endoscopic resection for patients with early-stage esophageal adenocarcinoma: A National Cancer Database propensity-matched study.
    Marino KA; Sullivan JL; Weksler B
    J Thorac Cardiovasc Surg; 2018 May; 155(5):2211-2218.e1. PubMed ID: 29455958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma.
    Feber A; Xi L; Pennathur A; Gooding WE; Bandla S; Wu M; Luketich JD; Godfrey TE; Litle VR
    Ann Thorac Surg; 2011 May; 91(5):1523-30. PubMed ID: 21420070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dilemma of T1 esophageal adenocarcinoma.
    Molena D; DeMeester SR
    J Thorac Cardiovasc Surg; 2017 May; 153(5):1206-1207. PubMed ID: 28314532
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of endoscopic therapy in early esophageal cancer.
    Malik S; Sharma G; Sanaka MR; Thota PN
    World J Gastroenterol; 2018 Sep; 24(35):3965-3973. PubMed ID: 30254401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments.
    Oh Y; Yoon SM; Lee J; Park JH; Lee S; Hong T; Chung LI; Sudhaman S; Riddell T; Palsuledesai CC; Krainock M; Liu MC; Chae YK
    Thorac Cancer; 2024 May; 15(13):1095-1102. PubMed ID: 38558374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer.
    Yang J; Gong Y; Lam VK; Shi Y; Guan Y; Zhang Y; Ji L; Chen Y; Zhao Y; Qian F; Chen J; Li P; Zhang F; Wang J; Zhang X; Yang L; Kopetz S; Futreal PA; Zhang J; Yi X; Xia X; Yu P
    Cell Death Dis; 2020 May; 11(5):346. PubMed ID: 32393783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.